Article
HMGB1 Promotes Drug Resistance in Osteosarcoma
19 Nov 2011
Abstract excerpt
Osteosarcoma is the most commonly occurring bone cancer in children and adolescents. Unfortunately, treatment failures are common due to the development of chemoresistance, for which the underlying molecular mechanisms remain unclear. In this study, we implicate the DNA-binding protein HMGB1, which also exerts immunoregulatory effects in its secreted form, in the development of drug resistance in osteosarcoma....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
